Skip to content
← Back to this collection

PUBLICATIONS · 25399551

Improved overall survival in melanoma with combined dabrafenib and trametinib.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2015 Jan 1
First author
Robert C

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Robert C
      type
      Author
    2. name
      Karaszewska B
      type
      Author
    3. name
      Schachter J
      type
      Author
    4. name
      Rutkowski P
      type
      Author
    5. name
      Mackiewicz A
      type
      Author
    6. name
      Stroiakovski D
      type
      Author
    7. name
      Lichinitser M
      type
      Author
    8. name
      Dummer R
      type
      Author
    9. name
      Grange F
      type
      Author
    10. name
      Mortier L
      type
      Author
    11. name
      Chiarion-Sileni V
      type
      Author
    12. name
      Drucis K
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Robert C
      type
      Author
    2. name
      Karaszewska B
      type
      Author
    3. name
      Schachter J
      type
      Author
    4. name
      Rutkowski P
      type
      Author
    5. name
      Mackiewicz A
      type
      Author
    6. name
      Stroiakovski D
      type
      Author
    7. name
      Lichinitser M
      type
      Author
    8. name
      Dummer R
      type
      Author
    9. name
      Grange F
      type
      Author
    10. name
      Mortier L
      type
      Author
    11. name
      Chiarion-Sileni V
      type
      Author
    12. name
      Drucis K
      type
      Author
    bibliography ids
    1. nci-bib-0ceda3bba06d6f7e18e90338
    book metadata
    content sha256
    471d82b987b05b54249cfe0610b33c89d44099cb9f62b9d5c7af3d95371ba62c
    document type
    citation
    dois
    1. 10.1056/NEJMoa1412690
    electronic publication date
    display
    2014 Nov 16
    precision
    day
    year
    2014
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:25399551
    immutable id
    pubmed:25399551@471d82b987b05b54249cfe0610b33c89d44099cb9f62b9d5c7af3d95371ba62c
    journal
    abbreviation
    N Engl J Med
    issn electronic
    1533-4406
    issn print
    0028-4793
    issue
    1
    name
    The New England journal of medicine
    nlm unique id
    0255562
    pages
    30-9
    volume
    372
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      25399551
      provenance
      batch id
      863b068fe5a07222af6a
      provider
      NCBI PubMed ESummary
      record sha256
      4fc9a485f4c8bebc43fffe474a7e7ff29678ebb0cdc2f696b43b485ff50c71fa
      response sha256
      80b1cc99e93fcfceb3e1b12ea433c615b032a2db13a615db7a6e9382c17c5034
      retrieved at
      2026-09-09T23:47:07.648963+00:00
      publication date
      display
      2015 Jan 1
      precision
      day
      year
      2015
      publication types
      1. Clinical Trial, Phase III
      2. Comparative Study
      3. Journal Article
      4. Multicenter Study
      5. Randomized Controlled Trial
      6. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/25399551/
      title
      Improved overall survival in melanoma with combined dabrafenib and trametinib.

      Preserved source evidence · Not medical advice